NETWORK appoints Medical Advisory Board
One of the first consequences of the Member Congress held in November is the appointment of a Medical Advisory Board...
This international Board shall have the task to examine treatment failures and deviations reported by members, to assess and comment on new publications about the lipodissolve issue and to clarify any questions addressed to us by members or patients. The Medical Advisory Board consists of the following doctors:
Dr. med. Franz Hasengschwandtner, Austria, Chairman
Dr. med. Patricia Ogilvie, Germany, priority: facial treatments
Dr. Lucy Glancey, MD, United Kingdom, priority: pain reduction
Dr. med. Horst Grübmeyer, Germany, priority: optimal treatment regions
Dr. med. Georg Popp, Germany, priority: combination of liposuction and lipolysis
Dr. Claudia van der Lugt, Netherland, priority: Lipodissolve injections and physicotherapy
Claus-Peter Meissner, Germany, priority: treatment failures
Dr. Patrick Treacy, MD, Ireland, priority: cellulite/mesotherapy
Dr. med. Eva Wegrostek, Austria, priority: emergency cases, anaphylactic shock and facial treatments
Bernhard Bieniek, Germany, priority: treatment of HIV patients
The members of the Advisory Board may also be contacted via their e-mail addresses. The first task of the Board consists in the assessment and evaluation of all publications made up to now with respect to the lipolysis topic and its scientific fundamentals. Another task of the Board will be the medical attendance of the cooperation with scientists who want to carry out studies.
Medical Advisory Board